GENEVA, Oct. 1 -- TIZIANA LIFE SCIENCES PLC filed a patent application (US2026/018653) for “ANTI-CD3 ANTIBODY COMBINATION THERAPIES FOR THE TREATMENT OF ALZHEIMER'S DISEASE”. With publication no. WO/2026/193123, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61P 25/28
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....